科研之友
微信
新浪微博
Facebook
分享链接
摘要
<正>1文献来源Chen J,Lu L,Wen T,et al. 2021 ESMO 945P-Adjuvant lenvatinib in combination with TACE for hepatocellular carcinoma patients with high risk of postoperative relapse (LANCE):Updated results from a multi-center prospective cohort study[J]. Ann Oncol,2021,32(5S):S818-S828.
- 单位
